Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Prospective, Multicenter, Post-marketing Clinical Follow-up Research to Evaluate the Long-term Safety of Ellansé-S Dermal Filler Made of PCL Microspheres for the Correction of Moderate-to-severe Nasolabial Folds

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06243315
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:27:51.965671+00:00
Published At
2025-04-29T00:00:00+00:00
Record Updated At
2025-04-29
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Moderate-to-severe Nasolabial Folds (3-4 Level of WSRS Scores) on Both Sides of the Face"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-04-29"
protocolSection.identificationModule.nctId
"NCT06243315"
protocolSection.identificationModule.officialTitle
"A Prospective, Multicenter, Post-marketing Clinical Follow-up Research to Evaluate the Long-term Safety of Ellans\u00e9-S Dermal Filler Made of PCL Microspheres for the Correction of Moderate-to-severe Nasolabial Folds"
protocolSection.statusModule.overallStatus
"ENROLLING_BY_INVITATION"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Moderate-to-severe Nasolabial Folds (3-4 Level of WSRS Scores) on Both Sides of the Face (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.